HSBC Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $966K | Buy |
106,787
+56,512
| +112% | +$511K | ﹤0.01% | 1413 |
|
|
2025
Q1 | $613K | Sell |
50,275
-472
| -0.9% | -$5.75K | ﹤0.01% | 1562 |
|
|
2024
Q4 | $656K | Buy |
50,747
+6,741
| +15% | +$87.2K | ﹤0.01% | 1639 |
|
|
2024
Q3 | $852K | Buy |
44,006
+409
| +0.9% | +$7.92K | ﹤0.01% | 1432 |
|
|
2024
Q2 | $884K | Buy |
43,597
+4,006
| +10% | +$81.2K | ﹤0.01% | 1412 |
|
|
2024
Q1 | $942K | Sell |
39,591
-9,127
| -19% | -$217K | ﹤0.01% | 1450 |
|
|
2023
Q4 | $1.05M | Buy |
+48,718
| New | +$1.05M | ﹤0.01% | 1374 |
|